Get the Stockscreener App
0.00
100.00%
-12.49
After Hours:
12.49
12.49
+
Avid Bioservices Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.
See More
Previous Close:
$12.49
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$798.90M
Revenue:
$150.45M
Net Income/Loss:
$-152.05M
P/E Ratio:
0.00
EPS:
-2.39
Net Cash Flow:
$-9.68M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$12.51
Avid Bioservices Inc Stock (CDMO) Company Profile
Name
Avid Bioservices Inc
Sector
Industry
Phone
714.508.6100
Address
14191 MYFORD ROAD, TUSTIN, CA
Compare CDMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDMO
Avid Bioservices Inc
|
0.00 | 798.90M | 150.45M | -152.05M | -9.68M | -2.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
512.52 | 131.61B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.36 | 73.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.97 | 37.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.44 | 32.81B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
266.26 | 28.62B | 3.81B | -644.79M | -669.77M | -6.24 |
Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-23 | Initiated | William Blair | Mkt Perform |
| Mar-14-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-08-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-17-21 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-10-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-17-19 | Initiated | Stephens | Overweight |
| Oct-16-19 | Initiated | Craig Hallum | Buy |
| Jun-28-19 | Upgrade | Janney | Neutral → Buy |
| May-09-19 | Downgrade | Janney | Buy → Neutral |
View All
Avid Bioservices Inc Stock (CDMO) Latest News
Proficio Capital Partners LLC Acquires New Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Acquired by Rhumbline Advisers - Defense World
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
New York State Common Retirement Fund Lowers Holdings in Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices, Inc. to Host Earnings Call - ACCESS Newswire
Ascentage Pharma Group International (NASDAQ:AAPG) versus Avid Bioservices (NASDAQ:CDMO) Critical Survey - Defense World
Avid Bioservices Goes Private Via $1.1 Billion Sale to PE Firms - Orange County Business Journal
UK: Acquisitions and strategic expansion across the CDMO value chain prioritised to accelerate Avid Bioservices growth - Investors in Healthcare
Avid Bioservices (NASDAQ:CDMO) Sets New 52-Week HighTime to Buy? - MarketBeat
Avid Bioservices Launches New Company Website Designed to - GlobeNewswire
Inside CDMO's Strategic Digital Transformation: Avid Bioservices Raises Industry Standards - StockTitan
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience - The Manila Times
1,117,104 Shares in Avid Bioservices, Inc. (NASDAQ:CDMO) Acquired by Jennison Associates LLC - MarketBeat
Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Sargent Investment Group LLC Trims Stake in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Janney Montgomery Scott LLC Sells 16,044 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners - GlobeNewswire
Tokio Marine Asset Management Co. Ltd. Makes New $7.32 Million Investment in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices Acquired by GHO and Ampersand Capital - TipRanks
Avid Bioservices, Inc. Announces Cessation of Board and Committee Members -February 05, 2025 at 11:50 am EST - Marketscreener.com
Avid Bioservices, Inc. Provides Notice of Fundamental - GlobeNewswire
Avid Bioservices' Noteholders Get Premium Deal: $1,422 Per $1K in Make-Whole Conversion - StockTitan
Major CDMO Acquisition: GHO Capital Snaps Up Avid Bioservices at 62% Premium - StockTitan
Avid Bioservices (NASDAQ:CDMO) Hits New 12-Month HighHere's Why - MarketBeat
Avid Bioservices, Inc. (NASDAQ:CDMO) Shares Purchased by SG Americas Securities LLC - Defense World
Avid Bioservices (NASDAQ:CDMO) Sets New 52-Week High – Still a Buy? - Defense World
Double Digit IRR Likely With Avid Bioservices Stock (NASDAQ:CDMO) - Seeking Alpha
Avid Bioservices Approves Merger with Space Finco - MSN
Avid Stockholders Approve Transaction with GHO and Ampersand -January 30, 2025 at 05:02 pm EST - Marketscreener.com
Avid Stockholders Approve Transaction with GHO and Ampersand - GlobeNewswire
Avid Shareholders Approve Acquisition by GHO, Ampersand -January 30, 2025 at 05:59 pm EST - Marketscreener.com
Avid Bioservices Shareholders Approve $1.1B Sale - Orange County Business Journal
Avid Bioservices Final Act: Shareholders Green-Light $1.2B Private Takeover - StockTitan
Trend Tracker for (CDMO) - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
McGuire Investment Group LLC Has $145,000 Stock Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
JPMorgan Chase & Co. Purchases 80,308 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World
JPMorgan Chase & Co. Has $1.24 Million Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat
Avid Bioservices Inc Stock (CDMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):